American Heart Association Clinical Series – serie

This book brings the recent dramatic changes in the field of cardiovascular imaging into the clinical setting to enable the clinician to best use the technology at hand. Novel Techniques for Imaging the Heart opens with three chapters reviewing the general considerations and fundamentals of imaging, followed by a series of chapters that address clinical applications of CT and CMR, including critical review of imaging approaches for diagnosis and prognosis of CADevaluating the patient with new onset heart failureevaluating the patient before non-cardiac surgeryevaluating the patient before interventional electrophysiologynovel assessment of vascular flow and valvular diseaserelative merits of CTA and MRA for coronary artery imagingThe final section deals with advanced applications of CT and MR imaging, considers technical advances and future prospects of high field MRI, and concludes with a chapter on image-guided cardiac interventions.The book includes a companion CD-ROM with a searchable database of figures from the book and 40 video clips fully referenced in the text.

Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine. The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around clinical scenarios rather than individual biomarkers. This book will help the practicing physician decide which biomarkers to measure, when to measure them, how to interpret the results and how to make decisions based on the test result.

This book in the new American Heart Association Clinical Series, explores and explains state-of-the-art use of antiplatelet agents and draws on the expertise of global leaders in antiplatelet therapy. Skillfully organized for fast reference, the book is divided into five parts: Concepts in Platelet Physiology, Function, and MeasurementPharmacology of Oral Antiplatelet AgentsPharmacology of Intravenous Antiplatelet AgentsClinical Use of Antiplatelet Agents in Cardiovascular DiseaseSpecial Circumstances.Each chapter in the clinical section contains an overview of guidelines, plus specifics on medical and interventional uses.Clinical cardiologists, platelet biologists, and a wide range of practicing and prospective clinicians in allied fields will find this text an exceptional source of current information.

Guides practicing physicians in the practical aspects of how to diagnose and treat patients with congenital heart diseaseReviews the most common congenital cardiac anomalies seen in practiceFocuses on both clinical evaluation and diagnostic imaging modalities as well as practical management issues, as well as when to refer patients to tertiary care centresEach chapter is preceded by a case study to exemplify the issues which may be challenging in practical management

This book is part of the AHA Clinical Series published in conjunction with the American Heart Association in order to focus on high-interest and emerging topics in cardiovascular disease targeted for cardiologists and other interested healthcare providers.  Cardiogenic shock causes over half of the deaths among patients hospitalized with ST-elevation myocardial infarction worldwide.  Therefore, its management is one of the most important aspects of the care of patients with acute MI.  Yet there is no single comprehensive source for information about this problem in the modern era; this book fills that gap. Drs. Hochman and Ohman offer an extremely useful tool for investigating, evaluating, and treating one of the most important lingering challenges in acute cardiovascular care.

The relationship of metabolic diseases to cardiovascular disease (CVD) is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes. This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation. Mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance/diabetes are also addressed, and the importance of interventions that reduce metabolic risk factors and CVD are covered.

This new title in the American Heart Association Clinical Series offers an up-to-date overview of the causes and damage related to dyssynchronopathy - a new pathophysiological entity related to spontaneous or pacing-induced mechanical abnormalities which causes heart failure.This is a critical and evolving area in cardiology, and this new book covers the state of the art issues, including: management of heart failureselection of the heart failure patient for device implantationdevice selectionprogramming and troubleshootingnon-invasive imaging of the heart failure patient.Pacing to Support the Failing Heart presents the most recent diagnostic non-invasive tools and offers multiple figures, tables, algorithms, summaries of clinical trials and clinically important information for all cardiologists, whilst providing simple, practice-oriented therapeutic proposals for heart failure patients.